KRROKorro Bio, Inc.

KRRO Stock Price, Valuation & Chart | Korro Bio, Inc.

Compare

$11.970-0.27 (-2.21%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology KRRO intrinsic value KRRO calculated fair value vs price

Overview Financials Dividends Ratios

KRRO Historical price chart

KRRO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization119.14M

PE Ratio-1.2

EPS-10.0

Trading Volume81.06K

Today's High/Low12.78/11.82

Dividend Yield0.00

52 Week High/Low55.89/5.2

Shares Outstanding9.95M

KRRO Financial Statement

KRRO Analyst ratings

KRRO Analysis & performance metrics

KRRO Company profile

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent…

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

KRRO Management team

Name

Position

Loic Vincent Ph.D.

Chief Scientific Officer

Kemi Olugemo M.D.

Chief Medical Officer

Ram Aiyar MBA, Ph.D.CEO

Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director

Andrew Fraley Ph.D.

Co-Founder & Advisor

Todd Chappell M.B.A.COO

Chief Operating Officer

Oliver Dolan

Senior Vice President of Finance & Principal Accounting Officer

Venkat Krishnamurthy Ph.D.

Senior Vice President & Head of Platform

Jeffrey M. Cerio J.D., Pharm.D.

Senior Vice President, General Counsel & Corporate Secretary

Name

Position

Loic Vincent Ph.D.

Chief Scientific Officer

Kemi Olugemo M.D.

Chief Medical Officer

Ram Aiyar MBA, Ph.D.CEO

Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director

Andrew Fraley Ph.D.

Co-Founder & Advisor

Todd Chappell M.B.A.COO

Chief Operating Officer

Oliver Dolan

Senior Vice President of Finance & Principal Accounting Officer

Venkat Krishnamurthy Ph.D.

Senior Vice President & Head of Platform

Jeffrey M. Cerio J.D., Pharm.D.

Senior Vice President, General Counsel & Corporate Secretary

Management Team

Loic Vincent Ph.D.

Chief Scientific Officer

Kemi Olugemo M.D.

Chief Medical Officer

Ram Aiyar MBA, Ph.D.CEO

Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director

Andrew Fraley Ph.D.

Co-Founder & Advisor

Todd Chappell M.B.A.COO

Chief Operating Officer

Oliver Dolan

Senior Vice President of Finance & Principal Accounting Officer

Venkat Krishnamurthy Ph.D.

Senior Vice President & Head of Platform

Jeffrey M. Cerio J.D., Pharm.D.

Senior Vice President, General Counsel & Corporate Secretary

Management

Loic Vincent Ph.D.

Chief Scientific Officer

Kemi Olugemo M.D.

Chief Medical Officer

Ram Aiyar MBA, Ph.D.CEO

Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director

Andrew Fraley Ph.D.

Co-Founder & Advisor

Todd Chappell M.B.A.COO

Chief Operating Officer

Oliver Dolan

Senior Vice President of Finance & Principal Accounting Officer

Venkat Krishnamurthy Ph.D.

Senior Vice President & Head of Platform

Jeffrey M. Cerio J.D., Pharm.D.

Senior Vice President, General Counsel & Corporate Secretary

Total 8 executives

KRRO Frequently asked questions

What is Korro Bio, Inc. (KRRO) Stock Price?

Current stock price of Korro Bio, Inc. (KRRO) stock is $11.970. The stock price is -2.21% lower in the session. The intraday range can be seen from this page. Volume of Korro Bio, Inc. (KRRO) stock is 81.06K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Korro Bio, Inc. (KRRO) stock price going up or down today?

The stock price of Korro Bio, Inc. (KRRO) can change with earnings, company news, and overall market sentiment. Korro Bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Korro Bio, Inc. stock expensive at its current price?

Whether Korro Bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KRRO on this page is -1.20. EPS on this page is -10.00. Compare those figures with peers and growth expectations before deciding if the current Korro Bio, Inc. price is justified.

How has the stock price of Korro Bio, Inc. (KRRO) performed historically?

Historical performance for Korro Bio, Inc. (KRRO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KRRO reacted to past earnings and market events.

Should I buy Korro Bio, Inc. (KRRO) stock, at this price?

Buying Korro Bio, Inc. (KRRO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.